SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-011256
Filing Date
2021-03-05
Accepted
2021-03-05 16:01:27
Documents
7
Period of Report
2021-03-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K alec-8k_20210305.htm 8-K 45932
2 GRAPHIC gavd4nofpgm5000006.jpg GRAPHIC 643
3 GRAPHIC gavd4nofpgm5000004.jpg GRAPHIC 4957
4 GRAPHIC gavd4nofpgm5000003.jpg GRAPHIC 4957
5 GRAPHIC gavd4nofpgm5000002.jpg GRAPHIC 4957
6 GRAPHIC gavd4nofpgm5000005.jpg GRAPHIC 634
7 GRAPHIC gavd4nofpgm5000001.jpg GRAPHIC 4957
  Complete submission text file 0001564590-21-011256.txt   77192
Mailing Address 151 OYSTER POINT BLVD., SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD., SUITE 300 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

IRS No.: 462702363 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38792 | Film No.: 21718434
SIC: 2836 Biological Products, (No Diagnostic Substances)